Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|January 2, 2023
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responsesAlba Llibre, Nikaïa Smith, Vincent Rouilly, et al.Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.Cell Reports|June 29, 2022
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activationCeline Posseme, Alba Llibre, Bruno Charbit, et al.Nature Communications|November 26, 2022
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severityNikaïa Smith, Céline Possémé, Vincent Bondet, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2015
Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in WomenMorgane Griesbeck, Susanne Ziegler, Sophie Laffont, et al.Nature Communications|July 17, 2021
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearanceRémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, et al.Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.Science Advances|July 5, 2023
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infectionMirja Harms, Nikaïa Smith, Mingyu Han, et al.Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.Science Advances|August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infectionNader Yatim, Jeremy Boussier, Pauline Tetu, et al.Pageof 4